E-clonal antibodies: Selection of full-length igg antibodies using bacterial periplasmic display

Nature Protocols

Volumn 3, Issue 11, 2008, Pages 1766-1777

  Mazor, Yariv ^a,b   Van Blarcom, Thomas ^a,b   Iverson, Brent L ^a   Georgiou, George ^a,b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b The University of Texas at Austin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PEPTIDE LIBRARY;

ARTICLE; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PLASMID; PROTEIN ENGINEERING;

ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; IMMUNOGLOBULIN G; PEPTIDE LIBRARY; PERIPLASM; PLASMIDS; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS;

EID: 58749094612     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2008.176     Document Type: Article

References (33)

1. Imai, K. and Takaoka, A.: Comparing antibody and small-molecule therapies for cancer. Nat. Rev. Cancer 6, 714-727 (2006).
2. Kohler, G. and Milstein, C.: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497 (1975).
3. Li, J.: Human antibodies for immunotherapy development generated via a human B cell hybridoma technology. Proc. Natl. Acad. Sci. USA 103, 3557-3562 (2006).
4. Fishwild, D. M.: High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice. Nat. Biotechnol. 14, 845-851 (1996).
5. Winter, G., Griffiths, A.D., Hawkins, R.E. and Hoogenboom, H.R.: Making antibodies by phage display technology. Annu. Rev. Immunol. 12, 433-455 (1994).
6. Boder, E.T. and Wittrup, K.D.: Yeast surface display for screening combinatorial polypeptide libraries. Nat. Biotechnol. 15, 553-557 (1997).
7. Daugherty, P.S., Olsen, M.J., Iverson, B.L. and Georgiou, G.: Development of an optimized expression system for the screening ofantibody libraries displayed on the Escherichia coli surface. Protein Eng. 12, 613-621 (1999).
8. Lipovsek, D. and Pluckthun, A.: In-vitro protein evolution by ribosome display and mRNA display. J. Immunol. Methods 290, 51-67 (2004).
9. Harvey, B.R.: Anchored periplasmicexpression, a versatile technology forthe isolation of high-affinity antibodies from Escherichia coli-expressed libraries. Proc. Natl. Acad. Sci. USA 101, 9193-9198 (2004).
10. Hoogenboom, H.R.: Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 23, 1105-1116 (2005).
11. Daugherty, P.S., Iverson, B.L. and Georgiou, G.: Flow cytometric screening of cell-based libraries. J. Immunol. Methods 243, 211-227 (2000).
12. Hayhurst, A. and Georgiou, G.: High-throughput antibody isolation. Curr. Opin. Chem. Biol. 5, 683-689 (2001).
13. Daugherty, P.S.: Protein engineering with bacterial display. Curr. Opin. Struct. Biol. 17, 474-480 (2007).
14. Chao, G.: Isolating and engineering human antibodies using yeast surface display. Nat. Protoc. 1, 755-768 (2006).
15. Benhar, I.: Design of synthetic antibody libraries. Expert Opin. Biol. Ther. 7, 763-779 (2007).
16. Chen, W. and Georgiou, G.: Cell-surface display of heterologous proteins: from high-throughput screening to environmental applications. Biotechnol. Bioeng. 79, 496-503 (2002).
17. Samuelson, P., Gunneriusson, E., Nygren, P.A. and Stahl, S.: Display of proteins on bacteria. J. Biotechnol. 96, 129-154 (2002).
18. Francisco, J.A., Earhart, C.F. and Georgiou, G.: Transport and anchoring of beta-lactamase to the external surface of Escherichia coli. Proc. Natl. Acad. Sci. USA 89, 2713-2717 (1992).
19. Chen, G.: Isolation of high-affinity ligand-binding proteins by periplasmic expression with cytometric screening (PECS). Nat. Biotechnol. 19, 537-542 (2001).
20. Daugherty, P.S., Chen, G., Olsen, M.J., Iverson, B.L. and Georgiou, G.: Antibody affinity maturation using bacterial surface display. Protein Eng. 11, 825-832 (1998).
21. Harvey, B.R.: Engineering of recombinant antibody fragments to methamphetamine by anchored periplasmic expression. J. Immunol. Methods 308,43-52 (2006).
22. Jeong, K.J., Seo, M.J., Iverson, B.L. and Georgiou, G.: APEx 2-hybrid, a quantitative protein-protein interaction assay for antibody discovery and engineering. Proc. Natl. Acad. Sci. USA 104, 8247-8252 (2007).
23. Worn, A. and Pluckthun, A.: Stability engineering of antibody single-chain Fv fragments. J. Mol. Biol. 305, 989-1010 (2001).
24. Mazor, Y., Blarcom, T.V., Mabry, R., Iverson, B.L. and Georgiou, G.: Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli. Nat. Biotechnol. 25, 563-565 (2007).
25. Nilsson, B.: Asynthetic IgG-binding domain based on staphylococcal protein A. Protein Eng. 1, 107-113 (1987).
26. Yu, F., Inouye, S. and Inouye, M.: Lipoprotein-28, a cytoplasmic membrane lipoprotein from Escherichia coli. Cloning, DNA sequence, and expression of its gene. J. Biol. Chem. 261, 2284-2288 (1986).
27. Yamaguchi, K., Yu, F. and Inouye, M.: A single amino acid determinant of the membrane localization of lipoproteins in E. coli. Cell 53, 423-432 (1988).
28. Dane, K.Y., Chan, L.A., Rice, J.J. and Daugherty, P.S.: Isolation of cell specific peptide ligands using fluorescent bacterial display libraries. J. Immunol. Methods 309, 120-129 (2006).
29. Akamatsu, Y., Pakabunto, K., Xu, Z., Zhang, Y. and Tsurushita, N.: Whole IgG surface display on mammalian cells: Application to isolation of neutralizing chicken monoclonal anti-IL-12 antibodies. J. Immunol. Methods 327, 40-52 (2007).
30. Raju, T.S., Briggs, J.B., Borge, S.M. and Jones, A.J.: Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 10, 477-486 (2000).
31. Radaev, S. and Sun, P.D.: Recognition of IgG by Fcgamma receptor. The role of Fc glycosylation and the binding of peptide inhibitors. J. Biol. Chem. 276, 16478-16483 (2001).
32. Jefferis, R. and Lund, J.: Interaction sites on human IgG-Fc for FcgammaR: current models. Immunol. Lett. 82, 57-65 (2002).
33. Simmons, L.C.: Expression offull-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies. J. Immunol. Methods 263, 133-147 (2002).